In line with this, LIPI was identified as a cancer/testes antigen (CTA), i.e., a group of immunogenic proteins showing predominant expression in gametogenic tissues and cancer and considered as interesting targets for anti-cancer vaccines [412,413]. Here, LIPI is linked to cancer.